Related Experiment Video
Updated: May 7, 2026

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection
Published on: July 21, 2022
Drugs to cure avian influenza infection--multiple ways to prevent cell death
1College of Resources and Environmental Sciences, Sichuan Agricultural University, Chengdu, China.
Abstract:
New treatments and new drugs for avian influenza virus (AIV) infection are developed continually, but there are still high mortality rates. The main reason may be that not all cell death pathways induced by AIV were blocked by the current therapies. In this review, drugs for AIV and associated acute respiratory distress syndrome (ARDS) are summarized. The roles of antioxidant (vitamin C) and multiple immunomodulators (such as Celecoxib, Mesalazine and Eritoran) are discussed. The clinical care of ARDS may result in ischemia reperfusion injury to poorly ventilated alveolar cells. Cyclosporin A should effectively inhibit this kind of damages and, therefore, may be the key drug for the survival of patients with virus-induced ARDS. Treatment with protease inhibitor Ulinastatin could also protect lysosome integrity after the infection. Through these analyses, a large drug combination is proposed, which may hypothetically greatly reduce the mortality rate.
Insights
New treatments for avian influenza virus (AIV) infection are insufficient. This review proposes a combination therapy including vitamin C, immunomodulators, Cyclosporin A, and Ulinastatin to reduce high mortality rates in AIV and acute respiratory distress syndrome (ARDS).
Area of Science:
- Virology
- Pharmacology
- Critical Care Medicine
Background:
- Avian influenza virus (AIV) infections continue to have high mortality rates despite ongoing treatment development.
- Current therapies may fail to block all cell death pathways induced by AIV, contributing to poor outcomes.
- Acute respiratory distress syndrome (ARDS) associated with AIV poses significant clinical challenges.
Purpose of the Study:
- To review existing and potential drug treatments for AIV infection and associated ARDS.
- To explore the roles of specific compounds like vitamin C, immunomodulators, Cyclosporin A, and Ulinastatin in managing AIV-induced ARDS.
- To propose a novel combination drug therapy to potentially reduce mortality rates.
Main Methods:
- Literature review of drugs for AIV and ARDS.
- Analysis of the mechanisms of action for antioxidants, immunomodulators, and other therapeutic agents.
- Hypothetical modeling of a combined drug treatment strategy.
Main Results:
- Vitamin C (antioxidant) and immunomodulators (Celecoxib, Mesalazine, Eritoran) show potential benefits.
- Cyclosporin A may prevent ischemia reperfusion injury in alveolar cells during ARDS clinical care.
- Ulinastatin could preserve lysosome integrity post-AIV infection.
Conclusions:
- A comprehensive drug combination, including the discussed agents, is proposed.
- This multi-drug approach may significantly decrease mortality in patients with virus-induced ARDS.
- Further research and clinical trials are warranted to validate this therapeutic strategy.
More Related Videos
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
08:46Rapid Diagnosis of Avian Influenza Virus in Wild Birds: Use of a Portable rRT-PCR and Freeze-dried Reagents in the Field
Published on: August 2, 2011
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Leaky Scanning
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...